Both in Pharmaceuticals
Verastem vs Kura Oncology
Over the past year VSTM returned −6.6% and KURA returned −10.1%; their daily moves had a correlation of 0.31.
VSTM −6.6% KURA −10.1%Growth of $1, one year, split-adjusted
| Metric | VSTM | KURA |
|---|---|---|
| Price | $8.78 | $9.26 |
| Market cap | $794.7M | $823.3M |
| Today | −4.93% | −4.59% |
| 1 month | +16.2% | −21.0% |
| 6 months | +33.4% | −4.4% |
| Year to date | +13.7% | −10.9% |
| 1 year | −6.6% | −10.1% |
| Revenue growth (YoY) | +1775.4% | +36.5% |
| Gross margin | 89.9% | 98.8% |
| Net margin | −86.5% | −327.3% |
| P/E (TTM) | — | — |
| Price / sales | 9.1× | 10.7× |
| Net cash | $54.6M | $509.2M |
| Dividend yield | — | — |
| Volatility (60d) | 71.3% | 54.9% |
| Short % of float | 17.7% | 18.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).